, Tracking Stock Market Picks
Enter Symbol:
Rating: ORPN
Buy $23

Bio Blast Pharma Ltd. (NASDAQ: ORPN) reiterated to Buy with price target $23 by Roth Capital

Wednesday,  Dec 9, 2015  9:25 AM ET by Lynn Gilbert

Roth Capital reiterated Bio Blast Pharma Ltd. (NASDAQ: ORPN) to Buy with price target
$23. Previously, Roth Capital rated Bio Blast Pharma Ltd. (NASDAQ: ORPN) to Buy with price target $25 on 06/15/2015, when the stock price was valued at $6.40.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy